Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Name
- INVIVYD, INC.
- Description
- Biotechnology
- Location
- Massachusetts · United States of America
Registrant
- Firm
- CGCN GROUP, LLC
- Description
- Public Affairs Consultants
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesDisaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
LobbyistsJILL HAMAKER · mrs MARTHA BEATRICE MILLER
Covered position (mrs MARTHA BEATRICE MILLER): Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022.
Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
LobbyistsJILL HAMAKER · mrs MARTHA BEATRICE MILLER
Covered position (mrs MARTHA BEATRICE MILLER): Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022.
Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.